Global COVID-19 Diagnostics Market – Industry Trends and Forecast to 2029

 Análise e dimensão do mercado de diagnóstico COVID-19

Os Centros de Controlo e Prevenção de Doenças (CDC) desenvolveram dois testes laboratoriais para identificar o SARS-CoV-2, o vírus que causa o COVID-19. O painel de diagnóstico RT-PCR em tempo real do CDC 2019-Novel Coronavirus (2019-nCoV), que deteta SARS-CoV-2 em amostras respiratórias, foi o primeiro teste distribuído para o diagnóstico de COVID-19 e foi lançado em fevereiro de 2020. Em julho de 2020, o CDC lançou o CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay, que permite aos laboratórios de saúde pública realizar três testes num único poço de reação. O Flu SC2 Multiplex utiliza menos reagentes de teste, tem um rendimento mais elevado e fornece resultados precisos para a presença de ácido nucleico de SARS-CoV-2, gripe A e gripe B numa amostra de paciente.

A Data Bridge Market Research analisa que o mercado de diagnósticos COVID-19, que foi de 46,76 mil milhões de dólares em 2021, deverá atingir os 86,55 mil milhões de dólares até 2029, com um CAGR de 8,00% durante o período de previsão de 2022 a 2029. Além dos insights sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análise especializada aprofundada, epidemiologia de doentes, análise de pipeline, análise de preços e enquadramento regulamentar.

Âmbito e segmentação do mercado de diagnóstico COVID-19  

Definição de mercado

O novo coronavírus é um coronavírus de RNA de cadeia simples que se assemelha ao SARS-CoV existente. Como se propaga através do contacto próximo com um indivíduo infetado e propaga-se principalmente através de gotículas respiratórias produzidas pela tosse e espirro. O coronavírus, que é agora uma epidemia global, foi descoberto pela primeira vez na área chinesa de Wuhan. É também conhecida como doença por coronavírus ou COVID-19. A RT-PCR, a amplificação isotérmica de ácido nucleico, a deteção de anticorpos e outras tecnologias são utilizadas nos kits de teste para o teste COVID-19, que é utilizado para identificar o vírus SARS-CoV-2. Os testes serológicos são empregues para vigilância populacional, diagnóstico e identificação de anticorpos.

Dinâmica global do mercado de diagnóstico COVID-19

Motoristas

• A necessidade de kits de teste nos hospitais é um fator determinante

A necessidade de kits de teste de coronavírus aumentou juntamente com a disseminação do coronavírus. Com a ajuda de kits de teste, a identificação do coronavírus tornou-se mais crucial do que nunca para controlar a propagação da infeção e impulsionar a expansão do mercado. Apenas laboratórios especializados e licenciados para realizar os testes incluídos neste kit, que são do tipo serológico e molecular. Uma vez que os kits são baseados em técnicas que incluem reações em cadeia da polimerase em tempo real, testes IgM ELISA e ensaios de microneutralização, são recolhidas amostras do nariz, teste de expetoração, amostra de sangue, esfregaço da garganta e aspirado nasal para teste. A procura pela indústria está a crescer como resultado do surto global de coronavírus. À medida que o número de doentes nos hospitais aumenta rapidamente, aumenta também a necessidade de kits de testes nos hospitais para diagnosticar os doentes com sintomas, o que impulsiona ainda mais o crescimento do mercado.

• Avanços tecnológicos nos testes rápidos de COVID-19

Vendors created a variety of innovative rapid testing kits, including cups, cards, and smart test kits. Saliva samples were employed in painless quick testing kits. Additionally, test kits with quicker findings were released on the market. Rapid testing is preferred over other COVID-19 testing kits as a result of these developments. For instance, Meril Diagnostics, an international medical firm with operations in India, produces the non-prescription CoviFind COVID-19 Rapid Antigen Self-Test, which is available and has received approval from the Indian Council of Medical Research (ICMR) for routine usage in India. The introduction of novel and innovative diagnostic tests, such as immunoenzymatic serological tests, rapid antigen tests, and RT PCR-based molecular tests, is expected to drive industry demand.

Opportunities

• Rising number of COVID-19 patients

With the rapidly increasing number of COVID-19 patients worldwide, healthcare professionals require a consistent supply of diagnostic kits, which is expected to have a significant impact on the COVID-19 diagnostics market from 2022 to 2029. The growing number of suspected cases and the need to ensure that test results are correct which has resulted in an increase in demand for more kits, as well as increased safety concerns and the need to diagnose and isolate infected persons, which are expected to boost market growth.

Restraints/Challenges

• Lack of knowledge regarding COVID-19

Lack of knowledge regarding COVID-19 and its symptoms, ability to increase in certain developing regions among professionals will obstruct the market's growth rate. Time required for result is more than 24 hours which is bit longer and will act as a restraint, and further challenge the growth of the COVID-19 Diagnostics market in the forecast period mentioned above. The increased number of false-positive and false-negative results is one of the main drawbacks of fast testing. A set of COVID-19 test kits contained instances of findings that were both falsely positive and falsely negative. When verified with alternate COVID-19 testing, individuals with COVID-19 symptoms both tested negative and positive. These incidents caused the use of COVID-19 fast test kits to decline in some countries.

This COVID-19 diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the COVID-19 diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the COVID-19 Diagnostics Market

COVID-19 had a positive impact on the market, by finding the sick person and person-to-person transmission, the testing significantly contributes to controlling and mitigating the pandemic. One of the most frequently used COVID-19 tests worldwide is rapid antigen testing. Results from this diagnosis, which quantifies the amount of viral protein, can be obtained in within 15 minutes. However, with time, more people started using fast diagnostics kits, and vendors also started making highly sensitive COVID-19 rapid test kits.

Recent developments

• In July 2021, Abbott launched the PanbioTM COVID-19 antigen self-test in India to expand its quick diagnostics offering to meet screening requirements at home, work, and clinics.
• In March 2021 Roche Diagnostics announced the permission for Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) for the COVID-19 rapid antigen test, which is intended for use by healthcare professionals in point-of-care situations with COVID-19 patients.

Global COVID-19 Diagnostics Market Scope

The COVID-19 diagnostics market is segmented on the basis of test type, product, technology, sample type, setting and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Molecular Assays
• Serologic Immunoassays
• Ancillary Diagnostic Tests

 Product

• Polymerase Chain Reaction Kits
• Point-of-care (POC) tests Kits
• Immunoassay
• Instruments
• Reagent and kits

 Technology

• Polymerase Chain Reaction (PCR)
• Enzyme Linked Immunosorbent Assay (ELISA)
• Lateral Flow Immunoassay (LFIA)
• Others

Sample Type

• Oropharyngeal and Nasopharyngeal Swabs
• Nasal Swabs
• Blood
• Others

 Setting

• Lab based
• Point of Care

 End User

• Hospitals
• Public Health Labs
• Private or Commercial Labs
• Urgent care clinics
• Physician Labs

COVID-19 Diagnostics Market Regional Analysis/Insights

The COVID-19 diagnostics market is analysed and market size insights and trends are provided by country, test type, product, technology, sample type, setting and end user as referenced above.

The countries covered in the COVID-19 diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the COVID-19 diagnostics market due to the well-established healthcare system and the presence of numerous existing pharma companies in this particular region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the increasing cases of coronavirus along with the presence of several industry players.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The COVID-19 diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for COVID-19 diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the COVID-19 diagnostics market. The data is available for historic period 2010-2020.

Competitive Landscape and COVID-19 Diagnostics Market Share Analysis

The COVID-19 diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to COVID-19 diagnostics market.

Some of the major players operating in the COVID-19 diagnostics market are:

• QIAGEN (Germany)
• F.Hoffmann-La Roche Ltd (Switzerland)
• Seegene Inc (South Korea)
• SolGent Co. Ltd (South Korea)
• Curetis (Germany)
• KURBO INDUSTRIES LTD. (Japan)
• Devex (U.S.)
• Thermo Fisher Scientific Inc (U.S.)
• Mylab Discovery Solutions Pvt. Ltd (India)
• Abbott (U.S)
• Getein Biotech, Inc (China)
• Biomaxima SA (Poland)
• CTK Biotech, Inc (U.S.)
• CDC (U.S.)
• BGI (China)
• Luminex Corporation (U.S.)
• Avellino.com (U.S.)
• PerkinElmer Inc (U.S.)
• Danaher (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)

SKU-55939